Early Access — free while we kick the tires
EdgarHawk

George Simeon

Director

Director
1 filing analyzed · 1 company · Latest 2025-07-17

Companies

Company Buys Sells Direction
CRISPR Therapeutics AG CRSP 3 0 Net buying

Activity

July 2025
2025-07-17 CRISPR Therapeutics AG CRSP
high
Buy
989,812 shares
$51,499,918
Significance 6/10

Director George Simeon bought 989,812 shares of CRSP for $51.5M at $52.03 on 2025-07-16 (3 separate transactions)

George Simeon, a Director, executed three separate open-market purchases totaling 989,812 shares for $51,499,918.36, increasing his holdings by 133.7% from 740,367 to 1,730,179 shares. The cumulative investment of $51.5M at a blended average of $52.03 represents a substantial capital commitment, and the stock currently trades at $55.09, 12.2% below its 52-week high and up 27.6% over the past 30 days and 45.9% over the past 90 days. However, Simeon's historical insider trade performance across all tickers is markedly poor: his prior two open-market purchases averaged 90-day returns of -38.7%, with a 0.00% win rate, suggesting his buying has not proven predictive of forward gains. Paired with the company's severe fundamental deterioration—revenue collapsed 90.0% year-over-year to only $865.0K in the latest quarter, net income declined to -$136.0M, and the company remains unprofitable—the large share purchase warrants scrutiny as to whether it reflects strategic conviction or other considerations such as retention, governance, or capital allocation constraints.

Related insiders

Create a free account

Build watchlists, get email alerts on the tickers you follow, and read the full AI analysis on every insider filing.

Sign up — free during early access